Literature DB >> 23096191

Evaluation of renal artery in hypertensive patients by unenhanced MR angiography using spatial labeling with multiple inversion pulses sequence and by CT angiography.

Yigang Pei1, Hao Shen, Jianjun Li, Haibing Zhang, Liming Xia, Liang Wang, Daoyu Hu.   

Abstract

OBJECTIVE: The purposes of this study were to determine the performance of a new unenhanced MR angiography (MRA) sequence, spatial labeling with multiple inversion pulses (SLEEK), with regard to its ability to present the renal arteries and to reveal renal artery disease in patients with secondary hypertension. SUBJECTS AND METHODS: Unenhanced MRA using SLEEK was performed on a 1.5-T MRI system for assessing renal arteries in 50 patients with hypertension. Then all patients underwent CT angiography (CTA) within 1-7 days. The ability to present the renal arteries and to reveal renal artery disease with SLEEK was evaluated by two experienced radiologists and was compared with CTA results using a joint reading performed in consensus.
RESULTS: Forty-six patients with hypertension successfully underwent SLEEK MRA. A total of 119 renal arteries were assessed, including 86 normal arteries, 26 with stenoses, and seven with fibromuscular dysplasia on CTA. There was excellent correlation between SLEEK and CTA in presenting the degree of renal artery stenosis (r(s) = 0.851; p < 0.05). SLEEK was superior to CTA in revealing the third- and fourth-order segmental branches in the renal parenchyma (p < 0.05). SLEEK has the advantage of avoiding interference from vertebra, atherosclerotic plaques, and early venous system enhancement.
CONCLUSION: Unenhanced MRA using SLEEK is a reliable diagnostic method for evaluating renal artery disease and revealing segmental branches in the renal parenchyma. It is relatively inexpensive and is not associated with renal complications. It can be used as an alternative to CTA for screening for renal artery disease, especially in patients with hypertension and renal insufficiency.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23096191     DOI: 10.2214/AJR.11.7263

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  7 in total

1.  Use of diffusion-weighted imaging in the noninvasive diagnostic of obstructed biliary ducts.

Authors:  Eliane Donato Leite Paro; Andrea Puchnick; Jacob Szejnfeld; Suzan Menasce Goldman
Journal:  Abdom Radiol (NY)       Date:  2020-07-14

2.  Non-contrast-enhanced abdominal MRA at 3 T using velocity-selective pulse trains.

Authors:  Dan Zhu; Wenbo Li; Dapeng Liu; Guanshu Liu; Yigang Pei; Taehoon Shin; Farzad Sedaghat; Qin Qin
Journal:  Magn Reson Med       Date:  2020-02-04       Impact factor: 4.668

3.  Hemodynamic study of unenhanced magnetic resonance angiography using spatial labeling with multiple inversion pulses sequence: a phantom study.

Authors:  Xiao Chen; Xiaoyan Meng; Di Zhu; Xianlun Zou; Yaqi Shen; Zhen Li; Jian Peng; Daoyu Hu
Journal:  Quant Imaging Med Surg       Date:  2021-05

Review 4.  Optimal management of renal artery fibromuscular dysplasia.

Authors:  Anders Gottsäter; Bengt Lindblad
Journal:  Ther Clin Risk Manag       Date:  2014-07-28       Impact factor: 2.423

5.  Accuracy of unenhanced magnetic resonance angiography for the assessment of renal artery stenosis.

Authors:  Carmen Sebastià; Alejandro D Sotomayor; Blanca Paño; Rafael Salvador; Marta Burrel; Albert Botey; Carlos Nicolau
Journal:  Eur J Radiol Open       Date:  2016-08-04

6.  Assessment of renal function using magnetic resonance quantitative histogram analysis based on spatial labeling with multiple inversion pulses.

Authors:  Ping Liang; Shichao Li; Chuou Xu; Jiali Li; Fangqin Tan; Daoyu Hu; Ihab Kamel; Zhen Li
Journal:  Ann Transl Med       Date:  2021-11

7.  Optimal Blood Suppression Inversion Time Based on Breathing Rates and Heart Rates to Improve Renal Artery Visibility in Spatial Labeling with Multiple Inversion Pulses: A Preliminary Study.

Authors:  Yigang Pei; Fang Li; Hao Shen; Xueying Long; Hui Liu; Xiaoyi Wang; Jinkang Liu; Wenzheng Li
Journal:  Korean J Radiol       Date:  2016-01-06       Impact factor: 3.500

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.